Friday, 19 Oct 2018

You are here

SLE-Scleroderma Overlap Outcomes

Overlap of autoimmune disorders represents a significant diagnostic and management challenge to the rheumatologist. A novel cohort analysis of overlap between systemic sclerosis (SSc) and systemic lupus erythematous (SLE) suggests such patients tend to be younger, more frequently have PAH, but less cutaneous manifestations of SSc.

Little is known about the epidemiology, clinical characteristics, and survival of SSc-SLE overlap. We evaluated the prevalence of SSc-SLE overlap and differences in SSc characteristics, and compared survival with SSc without SLE.

Among a large cohort of SSc patients (n=1252), they identified 66 patients with SSc-SLE with a prevalence of 6.8%.

SSc-SLE were younger at diagnosis (37.9 yrs vs 47.9 yrs, p < 0.001) than those with out SLE (SSc only). They were more frequently East Asian or South Asian, were positive for the lupus anticoagulant, anticardiolipin antibody and have pulmonary arterial hypertension (PAH; 52% vs 31%, p < 0.001).

At the same time they were less likely to have cutaneous features of SSc, including calcinosis (13% vs 27%, p = 0.007), telangiectasia (49% vs 75%, p < 0.001), and diffuse scleroderma (12% vs 35%, p < 0.001).

They were equally likely to experience renal crisis (7% vs 7%), interstitial lung disease (ILD; 41% vs 34%), or digital ulcers (38% vs 32%). As in all SSc, this subset should be monitored for ILD, renal crisis, and digital ulcers.

There was a trend towards better median survival in SSc-SLE patients, but this was not statistically significant (log-rank p = 0.06). 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Teenage Obesity Increases Lupus Risk

Analysis of the Black Women's Health Study shows that obesity as a teenager may be associated with increased risk of systemic lupus erythematous (SLE) in adulthood.

The relationship between obesity and SLE risk is unclear. Past studies have predominantly assessed white women, while black women have higher prevalence of both obesity and SLE.

Excess Mortality in CTD or Systemic Vasculitis Patients

The Norwegian connective tissue disease (CTD) and systemic vasculitis (PSV) registry (NOSVAR) studied patient outcomes over a 15 year period and found overall mortality to be higher in the CTD compared to the PSV group.

Mortality Improves in Lupus ESRD

The past two decades have seen a significant decline in mortality among patients with lupus nephritis, U.S. registry data indicated.

Ustekinumab May be Effective in Lupus

Ronald F van Vollenhoven and colleagues have reported in Lancet that ustekinumab (UST), an interleukin-12 and -23 inhibitor, when added to usual therapy in systemic lupus erythematosus (SLE) patients, was shown to be superior to placebo at improving clinical efficacy and laboratory parameters after 6 months of therapy.

An Association between GCA and IBD ?

A population based analysis from Israel suggests that giant cell arteritis (GCA) patients may be at increased risk for  inflammatory bowel diseases (IBD) mainly target.

This research was based on sporadic reports in the medical literature (http://bit.ly/2pnIPM0)